Research

Relentless Pursuit of a Healthier World

"Everything we do begins and ends with a patient in mind."

"Everything we do begins and ends with a patient in mind."

“Everything we do begins and ends with a patient in mind.” — Provost Robert A. Blouin, former dean of the UNC Eshelman School of Pharmacy

This core belief guides our pharmacy school day in and day out. From engineering stem cells to hunt and eradicate brain cancer to creating immersive learning technologies like the nXhumanTM, we innovate and drive transformational change in pharmacy research, education and practice.

In 2016, U.S. News & World Report ranked UNC Eshelman  the No. 1 school of pharmacy in recognition of our leadership  in education and patient care. This distinction means that we go beyond providing a first-rate education. We are shaping the future of pharmacy and pharmaceutical sciences. We are investing in high-risk, high-reward ideas in order to innovate from drug discovery to patient care at a faster rate than ever, and translate those discoveries into improved health for all.

The post Relentless Pursuit of a Healthier WorldOpens in new window appeared first on Carolina StoriesOpens in new window.

UNC Eshelman School of Pharmacy Funding Priorities

    Explore More Stories

    A group shot of Owen Fenton and his team in the Fenton Lab
    Faculty Support

    Attracting Expertise

    Owen Fenton sees coming to Carolina as a win for his research interests.

    Tim Willson stands with arms crossed with lab equipment in the background.
    Faculty Support

    Bringing the dark proteome into the light

    A Q&A with Tim Willson, the inaugural Harold Kohn Distinguished Professor in Open Science Drug Discovery

    A UNC Eshelman School of Pharmacy student takes notes during class.
    Health

    Strengthening Diversity, Improving Care

    Grants to the UNC Eshelman School of Pharmacy will support diversity and rural care programs.

    Nate Hathaway in the CRISPR Screening Facility
    Research

    UNC-Chapel Hill Awarded Funding for Study of Malan Syndrome

    UNC Eshelman School of Pharmacy and CRISPR Screening Facility collaborate on Malan Syndrome study.

    Health

    Smarter Organ Transplants

    The UNC Eshelman Institute for Innovation's Venture Studio invested in technology for smarter organ transplants.

    Shawn Hingtgen and Jillian Perry
    Research

    Treating the Untreatable

    New research funded by a NIH grant seeks to combat one of the most treatment-resistant cancers